Thomas Mueller

13PUBLICATIONS
27CO-AUTHORS
Proteins and peptidesElectrochemical energy storage and conversionMolecular targetsCancer cell biologyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Sep 13, 2025
Small Structural Changes in Chili-Derived Capsaicin Resulting in Nonivamide Analogs of Significantly Improved Cytotoxicity and Good Tumor/Non-Tumor Cell Selectivity.

Niels V Heise, René Csuk, Thomas Mueller

|Mar 28, 2024
Combination of Betulinic Acid Fragments and Carbonic Anhydrase Inhibitors-A New Drug Targeting Approach.

Matthias Bache, Niels V Heise, Andreas Thiel

|Jan 23, 2024
F16 Hybrids Derived from Steviol or Isosteviol Are Accumulated in the Mitochondria of Tumor Cells and Overcome Drug Resistance.

Niels V Heise, Julia Heisig, Kristof Meier

|Aug 26, 2023
Luciferase Expressing Preclinical Model Systems Representing the Different Molecular Subtypes of Colorectal Cancer.

Arne Rotermund, Martin S Staege, Sarah Brandt

|Jul 14, 2023
Palladium and Platinum Complexes of the Antimetabolite Fludarabine with Vastly Enhanced Selectivity for Tumour over Non-Malignant Cells.

Sebastian W Schleser, Oleksandr Krytovych, Tim Ziegelmeier

|Jul 14, 2023
Mitochondria-Targeting 1,5-Diazacyclooctane-Spacered Triterpene Rhodamine Conjugates Exhibit Cytotoxicity at Sub-Nanomolar Concentration against Breast Cancer Cells.

Niels Heise, Selina Becker, Thomas Mueller

Pageof 3

Frequent Collaborators

4 joint publications

Niels V Heise

4 joint publications

René Csuk

3 joint publications

Henrike Lucas

3 joint publications

Jana Lützkendorf